Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ingrid M. Hernandez"'
Publikováno v:
Oncology Reviews, Vol 2, Iss 3 (2011)
Over the past 30 years, there has been no significant improvement in treatment outcomes for patients with advanced stage IV metastatic melanoma, and prognosis remains poor. Melanoma is known to be responsive to immunomodulatory agents, to be a highly
Externí odkaz:
https://doaj.org/article/08b4ad4fd0b041fda0be0b43c7a7030d
Autor:
Nicholas E. Papadopoulos, Patrick Hwu, Chaan Ng, Wen-Jen Hwu, Luis H. Camacho, Kevin B. Kim, Ingrid M. Hernandez, Angela M. Frost, Agop Y. Bedikian, Monica A. Jack
Publikováno v:
Cancer Chemotherapy and Pharmacology. 64:161-167
In a search for more effective combination chemotherapy for the treatment of metastatic melanoma, we conducted a phase I trial of a novel combination of docetaxel, temozolomide, and cisplatin.Patients with inoperable or recurrent metastatic melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a54bbba98fa1811b7bb97af152bcdf7e
https://doi.org/10.1007/s00280-008-0861-0
https://doi.org/10.1007/s00280-008-0861-0
Autor:
Changping Li, Viviana Bozon, Luis H. Camacho, Bang Ning Lee, Jesus Gomez-Navarro, Charla A. Parker, James M. Reuben, Ingrid M. Hernandez, Carolina Gutierrez, Gabriel Lopez-Berestein
Publikováno v:
Cancer. 106:2437-2444
BACKGROUND T-regulatory (TR) cells expressing cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) maintain peripheral immune tolerance and negatively affect host immune responses against cancer. The immunobiologic effects of ticilimumab, a human mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c560f1213a9bc8245251c77a44a1d4c3
https://doi.org/10.1002/cncr.21854
https://doi.org/10.1002/cncr.21854
Autor:
James M, Reuben, Bang-Ning, Lee, Changping, Li, Jesus, Gomez-Navarro, Viviana A, Bozon, Charla A, Parker, Ingrid M, Hernandez, Carolina, Gutierrez, Gabriel, Lopez-Berestein, Luis H, Camacho
Publikováno v:
Cancer. 106(11)
T-regulatory (TR) cells expressing cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) maintain peripheral immune tolerance and negatively affect host immune responses against cancer. The immunobiologic effects of ticilimumab, a human monoclonal ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::66e82dfe9a21d56c906688ba5bb9dc75
https://pubmed.ncbi.nlm.nih.gov/16615096
https://pubmed.ncbi.nlm.nih.gov/16615096
Autor:
Ingrid M. Hernandez, Wayne Rackoff, Alessandra Ferrajoli, Stefan Faderl, Guillermo Garcia-Manero, Deborah A. Thomas, Hagop M. Kantarjian, Jorge E. Cortes, Moshe Talpaz, Susan O'Brien
Publikováno v:
Blood. 104:1011-1011
Tipifarnib (ZARNESTRA™, R115777) is an orally bioavailable nonpetidomimetic farnesyl transferase inhibitor (FTI) with significant anti-tumor activity in several tumor models. FTI have significant anti-leukemia activity in vitro against CML cell lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92f67957016bb526e0e42bcea58ab192
https://doi.org/10.1182/blood.v104.11.1011.1011
https://doi.org/10.1182/blood.v104.11.1011.1011
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 77:405-411
Pregnancy outcome and maternal morbidity were analysed in 302 pregnant women with positive Machado-Guerreiro Complement Fixation Test (MGCFT) for antibodies to Trypanosoma cruzi and 302 women with a negative MGCFT resident of Córdoba, Argentina. A c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e02c1718771038203a4057871f1eff0
https://doi.org/10.1016/0035-9203(83)90174-8
https://doi.org/10.1016/0035-9203(83)90174-8